Diagnosis and Treatment of Polycystic Ovary Syndrome


Polycystic ovary syndrome is the common endocrinopathy among reproductive-aged females in the all over the world, affecting approximately 6% of female patients. The pathophysiology of the disease is complex and there is no single defect from which it is known to result, it is hypothesized that insulin resistance is a key factors from asymptomatic to having multiple gynecologic, dermatologic, or metabolic manifestations. Advices from the Endocrine Society mentioned using the Rotterdam criteria for diagnosis, which mandate the presence of two of the following three findings—hyperandrogenism, ovulatory dysfunction, and polycystic ovaries and plus the exclusion of other diagnoses that could result in ovulatory dysfunction.


    Related Conference of Diagnosis and Treatment of Polycystic Ovary Syndrome

    October 12-13, 2023

    11th International Conference on Gynecology and Obstetrics

    Budapest, Hungary
    November 06-07, 2023

    10thAsia Pacific Gynecology and Obstetrics Congress

    Singapore City, Singapore
    November 15-16, 2023

    15th International Conference on Gynecology

    Edinburgh, Scotland
    November 16-17, 2023

    8th World Congress on Polycystic Ovarian Syndrome & Infertility

    Amsterdam, Netherlands
    February 01-02, 2024

    9th Annual Pediatric Congress

    Dubai, UAE
    March 18-19, 2024

    11th International Conference on Gynecology and Obstetrics

    Zurich, Switzerland

    Diagnosis and Treatment of Polycystic Ovary Syndrome Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in